You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 63 No. 12, December 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in this journal
 Topic Collections
 •Statistics and Research Methods
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic

COMMENTS AND OPINIONS
Data vs Conclusions in the Optic Neuritis Vaccination Investigation

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Regarding the study of vaccinations and subsequent optic neuritis by the Centers for Disease Control and Prevention (CDC),1 the authors made a curious choice of statistical methods. They had access to the Defense Medical Surveillance System (DMSS), an extremely rich database that includes all immunizations, diagnoses for all inpatient and outpatient medical encounters, and additional information for more than 10 million military person-years.

Power

Instead of using this database to perform a highly powered study, a case-control method was chosen, although this method is known to provide relatively weak evidence and is often subject to bias, especially in the selection of controls. The study's power was reduced further by restricting the duration of analysis to 6-, 12-, and 18-week periods following vaccination rather than leaving open-ended the period during which optic neuritis cases were diagnosed after vaccination. In 2003, a congressionally mandated Institute of Medicine report urged the CDC to use . . . [Full Text of this Article]


Controls

AUTHOR INFORMATION
Meryl Nass, MD


RELATED LETTERS

Data vs Conclusions in the Optic Neuritis Vaccination Investigation—Reply
Daniel C. Payne, Charles E. Rose, Jr, John Kerrison, Aaron Aranas, Susan Duderstadt, and Michael M. McNeil
Arch Neurol. 2006;63(12):1810.
EXTRACT | FULL TEXT  

Optic Neuritis and Vaccination Investigation: Failure to Consider Significant Sex Differences and Multiple Vaccine Combinations
Renata J. M. Engler, Mary Klote, and Michael R. Nelson
Arch Neurol. 2007;64(11):1673-1674.
EXTRACT | FULL TEXT  

Optic Neuritis and Vaccination Investigation: Failure to Consider Significant Sex Differences and Multiple Vaccine Combinations—Reply
Daniel C. Payne, Charles E. Rose, Jr, John Kerrison, Aaron Aranas, Susan Duderstadt, and Michael M. McNeil
Arch Neurol. 2007;64(11):1674-1675.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Optic Neuritis and Vaccination Investigation: Failure to Consider Significant Sex Differences and Multiple Vaccine Combinations
Engler et al.
Arch Neurol 2007;64:1673-1674.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.